Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Jan;41(1):59-67.
doi: 10.1007/s00259-013-2532-6. Epub 2013 Aug 24.

Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients

H Palmedo  1 , C Marx, A Ebert, B Kreft, Y Ko, A Türler, R Vorreuther, U Göhring, H H Schild, T Gerhardt, U Pöge, S Ezziddin, H-J Biersack, H Ahmadzadehfar
Affiliations
Clinical Trial

Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients

H Palmedo et al. Eur J Nucl Med Mol Imaging. 2014 Jan.

Abstract

Purpose: This study was designed to assess the additional value of SPECT/CT of the trunk used in conjunction with conventional nuclear imaging and its effects on patient management in a large patient series.

Methods: In 353 patients, whole-body scintigraphy (WBS), SPECT, and SPECT/CT were prospectively performed for staging and restaging. SPECT/CT of the trunk was performed in all patients. In the 308 evaluable patients (211 with breast cancer, 97 with prostate cancer), clinical follow-up was used as the gold standard. Bone metastases were confirmed in 72 patients and excluded in 236. Multistep analyses per lesion and per patient were performed. Clinical relevance was expressed in terms of downstaging and upstaging rates on a per-patient basis.

Results: In the total patient group, sensitivities, specificities, and negative and positive predictive values on a per-patient basis were 93 %, 78 %, 95 % and 59 % for WBS, 94 %, 71 %, 97 % and 53 % for SPECT, and 97 %, 94 %, 97 % and 88 % for SPECT/CT, respectively. In all subgroups, specificity and positive predictive value were significantly (p<0.01) better with SPECT/CT. Downstaging of metastatic disease in the total, breast cancer and prostate cancer groups using SPECT/CT was possible in 32.1 %, 33.8 % and 29.5 % of patients, respectively. Upstaging in previously negative patients by additional SPECT/CT was observed in three breast cancer patients (2.1 %). Further diagnostic imaging procedures for unclear scintigraphic findings were necessary in only 2.5 % of patients. SPECT/CT improved diagnostic accuracy for defining the extent of multifocal metastatic disease in 34.6 % of these patients.

Conclusions: SPECT/CT significantly improved the specificity and positive predictive value of bone scintigraphy in cancer patients. In breast cancer patients, we found a slight increase in sensitivity. SPECT/CT had a significant effect on clinical management because of correct downstaging and upstaging, better definition of the extent of metastases, and a reduction in further diagnostic procedures.

PubMed Disclaimer

References

    1. Ann Oncol. 2012 Apr;23(4):834-43 - PubMed
    1. Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):706-13 - PubMed
    1. AJR Am J Roentgenol. 2004 Sep;183(3):655-61 - PubMed
    1. Chest. 2007 Sep;132(3 Suppl):178S-201S - PubMed
    1. Hum Pathol. 2000 May;31(5):578-83 - PubMed

Publication types

LinkOut - more resources